|
|
|
|
 |
Press Releases
All Releases
 |
Pain Therapeutics Encouraged by Results of Melanoma Clinical Study
Jun 16, 2008
|
11.6 KB |
|
| |
SAN MATEO, Calif., Jun 16, 2008 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) announced today the successful completion of its first clinical study utilizing a novel melanoma treatment. This treatment consisted of dosing patients with a monoclonal antibody labeled with a radio-isotope. The Company owns exclusive w...
|
|
Pain Therapeutics and King Pharmaceuticals Announce Submission of New Drug Application for Remoxy
Jun 10, 2008
|
13.6 KB |
|
| |
SAN MATEO, Calif. and BRISTOL, Tenn., Jun 10, 2008 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) and King Pharmaceuticals, Inc. (NYSE:KG) today announced that a New Drug Application (NDA) for Remoxy(tm) has been submitted to the U.S. Food and Drug Administration (FDA). Remoxy, a unique long-acting formulation of o...
|
|
Pain Therapeutics to Present At Two Upcoming Investor Conferences
Jun 3, 2008
|
8.8 KB |
|
| |
SAN MATEO, Calif., Jun 3, 2008 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management is scheduled to present at the following investor conferences:
* Goldman Sachs Global Healthcare Conference in Laguna Niguel,
California
Tuesday, June 10th at 3:20 p.m. Pacific Tim...
|
|
Pain Therapeutics Announces First Quarter 2008 Financial Results
May 7, 2008
|
15.7 KB |
|
| |
SAN MATEO, Calif., May 7, 2008 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a biopharmaceutical company, today reported financial results for the three months ended March 31, 2008. Net income for the quarter ended March 31, 2008 was $2.6 million, or $0.06 per share, compared to net income of $12.6 million, or $0...
|
|
Pain Therapeutics Increases Stock Buyback Plan to $30,000,000
Mar 31, 2008
|
10.6 KB |
|
| |
SAN MATEO, Calif., Mar 31, 2008 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) announced today it has increased the size of its stock buyback plan to $30.0 million, effective immediately through March 2009. This represents a 50% increase from the Company's previously announced buyback plan. The Company has purchase...
|
|
Pain Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results
Feb 7, 2008
|
12.5 KB |
|
| |
SAN MATEO, Calif., Feb. 7, 2008 (PRIME NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a biopharmaceutical company, today reported financial results for the year and fourth quarter ended December 31, 2007.
Net income for the year ended December 31, 2007 was $20.3 million, or $0.44 per diluted share, compared to net income of $6.2 mi...
|
|
Pain Therapeutics Announces New Board Member
Dec 11, 2007
|
5.2 KB |
|
| |
SAN MATEO, Calif., Dec. 11, 2007 (PRIME NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced the appointment of Patrick J. Scannon, M.D., Ph.D., to the Company's Board of Directors as an independent director effective December 7, 2007. Dr. Scannon replaces Mr. Vernon Loucks, who will remain a close advisor to the Company.
D...
|
|
Remoxy Meets Primary Endpoint in Pivotal Phase III Study
Dec 6, 2007
|
10.3 KB |
|
| |
SAN MATEO, Calif. and BRISTOL, Tenn., Dec 6, 2007 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) and King Pharmaceuticals, Inc. (NYSE:KG) are pleased to announce positive results of a Phase III study of Remoxy(tm) in patients with chronic pain. Over 400 patients with osteoarthritis participated in this pivotal ...
|
|
Pain Therapeutics Invited to Present at the Credit Suisse Healthcare Conference
Nov 6, 2007
|
4.7 KB |
|
| |
SAN MATEO, Calif., Nov 6, 2007 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management will present at the 2007 Credit Suisse Healthcare Conference on Tuesday, November 13th at 5:00 p.m. Mountain Time in Phoenix, Arizona.
A live audio webcast of the presentation will be open to all...
|
|
Pain Therapeutics Announces Third Quarter 2007 Financial Results
Nov 1, 2007
|
10.9 KB |
|
| |
SAN MATEO, Calif., Nov 1, 2007 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today reported financial results for the three and nine months ended September 30, 2007. Net income for the quarter ended September 30, 2007 was $3.2 million, or $0.07 per diluted share, compared to $9.7 million, or $0.21 per diluted ...
|
|
Pain Therapeutics Selected for Inclusion in New NASDAQ Index
Sep 25, 2007
|
4.3 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Sep 25, 2007 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) has been selected as one of the inaugural companies in the new NASDAQ(r) NeuroInsights(r) Neurotech Index. This new index is being launched today.
The Neurotech Index tracks the stock performance of 32 companies eng...
|
|
Pain Therapeutics to Present At Three Upcoming Investor Conferences
Sep 11, 2007
|
3.8 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Sep 11, 2007 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management is scheduled to present at the following investor conferences:
* Merriman Curhan Ford 4th Annual Investor Summit in San Francisco Monday, September 17th at 4:00 p.m. Pacific Time
...
|
|
Pain Therapeutics Announces Second Quarter 2007 Financial Results
Aug 9, 2007
|
11.0 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., Aug 9, 2007 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today reported financial results for the three and six months ended June 30, 2007. Net income for the quarter ended June 30, 2007 was $3.4 million, or $0.07 per diluted share, compared to $1.4 million, or $0.03 per share, in...
|
|
Patient Recruitment Completed for Pivotal Phase III Study of Remoxy
Jul 11, 2007
|
7.2 KB |
|
| |
SOUTH SAN FRANCISCO, Calif. and BRISTOL, Tenn., Jul 11, 2007 (PrimeNewswire via COMTEX News Network) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) and King Pharmaceuticals, Inc. (NYSE:KG) announced today they have reached the enrollment target of 400 patients for a Phase III study with Remoxy(tm). Remoxy, an investigational drug, is a proprietary ab...
|
|
Pain Therapeutics to Present At the Goldman Sachs Healthcare Conference
Jun 6, 2007
|
3.9 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., June 6, 2007 (PRIME NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a biopharmaceutical company, today announced that management will present at the Goldman Sachs 28th Annual Global Healthcare Conference on Tuesday, June 12th at 4:00 p.m. Pacific Time in Laguna Niguel, California.
A live audio webcast of ...
|
|
Pain Therapeutics to Present at Two Upcoming Investor Conferences
May 22, 2007
|
4.0 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., May 22, 2007 (PRIME NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management is scheduled to present at the following investor conferences:
-- Friedman, Billings, Ramsey & Co. 2007 Growth Conference in New York Wednesday, May 30th at 12:50 p.m. Eastern Time
-- Bank of ...
|
|
Pain Therapeutics Announces First Quarter 2007 Financial Results
May 2, 2007
|
10.0 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., May 2 /PRNewswire-FirstCall/ -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, today reported financial results for the three months ended March 31, 2007. Net income for the quarter ended March 31, 2007 was $12.6 million, or $0.28 per share, compared to net income of $0.9 million, or $0.02 per ...
|
|
Pain Therapeutics Announces $20 Million Stock Buyback Plan
Mar 29, 2007
|
5.5 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., March 29 -- Pain Therapeutics, Inc. (Nasdaq: PTIE) announced today that its Board of Directors has authorized the purchase of up to $20 million of its common stock in the open market.
"We believe our financial situation enables us to implement a stock buyback while continuing to finance future growth,&qu...
|
|
Pain Therapeutics Licenses Biotechnology To Treat Rare Disorder
Mar 22, 2007
|
7.8 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., March 22 /PRNewswire-FirstCall/ -- Pain Therapeutics, Inc. (Nasdaq: PTIE) announced today it has licensed new technology to treat hemophilia, a rare blood disorder. The technology, originally developed by researchers at Stanford University School of Medicine, is expected to enter the clinic in 2008.
"Thi...
|
|
Pain Therapeutics Cleared to Initiate Phase I Study in Metastatic Melanoma
Mar 20, 2007
|
6.6 KB |
|
| |
SOUTH SAN FRANCISCO, Calif., March 20 -- Pain Therapeutics, Inc. (Nasdaq: PTIE) announced today it has received approval from the Ministry of Health in Israel to begin human testing of a new treatment for metastatic melanoma, a deadly form of skin cancer.
Pain Therapeutics' initial Phase I study is designed to evaluate the pharmacokineti...
|
|
|
= add release to Briefcase
|
   |
|
|
|
|
|
